Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

Fluridil safely promotes hair growth in men with androgenetic alopecia.

A woman's liver problems improved after she stopped taking spironolactone.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Urologic diseases and treatments in older men can negatively affect fertility, and doctors should talk to patients about this.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Steroid hormones are crucial for body functions and have various medical uses, but their misuse can lead to dependence.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Sex hormones do not cause oral lichen planus.

Oral lichen planus is not linked to sex hormone levels.

Fetal environments contain various chemicals that may disrupt hormones.

Some chemicals and drugs can cause hair loss, which usually grows back after stopping the treatment.

Sex hormones affect reproduction, sexual development, and oral health, and it's important for dental practitioners to understand their effects and interactions.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.